Abstract |
A trial to evaluate the safety and immunogenicity of recombinant modified vaccinia Ankara (MVA) and fowlpox (FP) vectors expressing multiple HIV-1 proteins was conducted in twenty HIV-1 infected youth with suppressed viral replication on HAART. The MVA and FP-based multigene HIV-1 vaccines were safe and well tolerated. Increased frequencies of HIV-1 specific CD4+ proliferative responses and cytokine secreting cells were detected following immunization. Increased frequencies and breadth of HIV-1 specific CD8 T-cell responses were also detected. Plasma HIV-1-specific antibody levels and neutralizing activity were unchanged following vaccination. Poxvirus-based vaccines may merit further study in therapeutic vaccine protocols.
|
Authors | Thomas C Greenough, Coleen K Cunningham, Petronella Muresan, Margaret McManus, Deborah Persaud, Terry Fenton, Piers Barker, Aditya Gaur, Dennis Panicali, John L Sullivan, Katherine Luzuriaga, Pediatric AIDS Clinical Trials Group P1059 Team |
Journal | Vaccine
(Vaccine)
Vol. 26
Issue 52
Pg. 6883-93
(Dec 09 2008)
ISSN: 0264-410X [Print] Netherlands |
PMID | 18940219
(Publication Type: Clinical Trial, Phase I, Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
|
Chemical References |
- AIDS Vaccines
- Cytokines
- Gene Products, gag
- HIV Antibodies
- RNA, Viral
- Vaccines, Synthetic
- Interferon-gamma
|
Topics |
- AIDS Vaccines
(adverse effects, immunology)
- Adolescent
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- CD4-CD8 Ratio
- Cytokines
(biosynthesis)
- Female
- Flow Cytometry
- Fowlpox virus
(immunology)
- Gene Products, gag
(biosynthesis, genetics)
- HIV Antibodies
(analysis, biosynthesis)
- HIV Infections
(drug therapy, immunology)
- HIV-1
(genetics, immunology)
- Humans
- Interferon-gamma
(biosynthesis)
- Male
- Prospective Studies
- RNA, Viral
(analysis, biosynthesis)
- T-Lymphocytes
(immunology)
- Vaccines, Synthetic
(immunology)
- Vaccinia
(immunology)
- Young Adult
|